Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Somnath Sarkar

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Archives of Internal Medicine|May 22, 2002
Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosisMichael Maricic, Jonathan D Adachi, Somnath Sarkar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancerFairooz F Kabbinavar, Julie Hambleton, Robert D Mass, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 5, 2002
Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapySomnath Sarkar, Bruce H Mitlak, Mayme Wong, et al.
Clinical Pharmacology and Therapeutics|December 28, 2024
POP-REFINE: A Comprehensive Framework for Evaluating and Optimizing Representativeness in Clinical TrialsCorey M Benedum, Somnath Sarkar, Selen Bozkurt, et al.
Cancers|July 9, 2022
Considerations for the Use of Machine Learning Extracted Real-World Data to Support Evidence Generation: A Research-Centric Evaluation FrameworkMelissa Estevez, Corey M Benedum, Chengsheng Jiang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 26, 2004
Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture riskSomnath Sarkar, Jean-Yves Reginster, Gerald G Crans, et al.
Pharmacoepidemiology and Drug Safety|July 6, 2021
Differential frequency in imaging-based outcome measurement: Bias in real-world oncology comparative-effectiveness studiesBlythe J S Adamson, Xinran Ma, Sandra D Griffith, et al.
JNCI Cancer Spectrum|September 13, 2024
Mediators of racial and ethnic inequities in clinical trial participation among patients with cancer, 2011-2023Jenny S Guadamuz, Xiaoliang Wang, Ivy Altomare, et al.
Current Medical Research and Opinion|March 18, 2004
Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trialEdward G Lufkin, Somnath Sarkar, Pandurang M Kulkarni, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 14, 2022
Accounting for Delayed Entry in Analyses of Overall Survival in Clinico-Genomic DatabasesDaniel Backenroth, Jeremy Snider, Ronglai Shen, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Archives of Internal Medicine|May 22, 2002
Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosisMichael Maricic, Jonathan D Adachi, Somnath Sarkar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancerFairooz F Kabbinavar, Julie Hambleton, Robert D Mass, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 5, 2002
Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapySomnath Sarkar, Bruce H Mitlak, Mayme Wong, et al.
Clinical Pharmacology and Therapeutics|December 28, 2024
POP-REFINE: A Comprehensive Framework for Evaluating and Optimizing Representativeness in Clinical TrialsCorey M Benedum, Somnath Sarkar, Selen Bozkurt, et al.
Cancers|July 9, 2022
Considerations for the Use of Machine Learning Extracted Real-World Data to Support Evidence Generation: A Research-Centric Evaluation FrameworkMelissa Estevez, Corey M Benedum, Chengsheng Jiang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 26, 2004
Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture riskSomnath Sarkar, Jean-Yves Reginster, Gerald G Crans, et al.
Pharmacoepidemiology and Drug Safety|July 6, 2021
Differential frequency in imaging-based outcome measurement: Bias in real-world oncology comparative-effectiveness studiesBlythe J S Adamson, Xinran Ma, Sandra D Griffith, et al.
JNCI Cancer Spectrum|September 13, 2024
Mediators of racial and ethnic inequities in clinical trial participation among patients with cancer, 2011-2023Jenny S Guadamuz, Xiaoliang Wang, Ivy Altomare, et al.
Current Medical Research and Opinion|March 18, 2004
Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trialEdward G Lufkin, Somnath Sarkar, Pandurang M Kulkarni, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 14, 2022
Accounting for Delayed Entry in Analyses of Overall Survival in Clinico-Genomic DatabasesDaniel Backenroth, Jeremy Snider, Ronglai Shen, et al.
Pageof 3